Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-26

Clinical Trial Update: Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate [Phase 3]

View source ↗

Summary

Phase 3 trial comparing standard steroid treatment to combined steroid & mycophenolate for newly diagnosed immune thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MycoPhenolate (mycophenolate mofetil)
  • Steroid (steroid)

Snippet

Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust | Conditions: Immune Thrombocytopenia | Phase 3 | Status: COMPLETED